SCOLR Pharma, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$2.0M

238 transactions

Summary

SCOLR Pharma, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $437KSales: $601K16 insiders

Date	Insider	Type	Value
2012-02-02	LEVY RICHARD M(CFO & Exec. VP Finance)	A	$0
2012-02-02	TURNER STEPHEN(President & CEO)	A	$0
2011-06-16	TAGLICH MICHAEL N	Buy	—
2011-06-09	Arnett Marylou W	A	$0
2011-06-09	JOHNSON CARL J	A	$0
2011-06-09	LUCAS HERBERT L JR	A	$0
2011-06-09	PINES WAYNE L	A	$0
2011-06-09	TAGLICH MICHAEL N	A	$0
2011-06-09	Jeffrey Reich	A	$0
2010-09-24	JOHNSON CARL J	A	$0
2010-06-10	Arnett Marylou W	A	$0
2010-06-10	Arnett Marylou W	A	$0
2010-06-10	JOHNSON CARL J	A	$0
2010-06-10	JOHNSON CARL J	A	$0
2010-06-10	LUCAS HERBERT L JR	A	$0
2010-06-10	PINES WAYNE L	A	$0
2010-06-10	TAGLICH MICHAEL N	A	$0
2010-06-10	Jeffrey Reich	A	$0
2010-01-04	MORRA BRUCE S	A	$0
2009-10-28	MITCHEL ALAN M(Sr. VP - Chief Legal Officer)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

SCOLR Pharma, Inc. — Contributions, Lobbying & Contracts | Poliscope